Westfield Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40.1M | Sell |
|
|||||
|
2025
Q2 | $60.9M | Sell |
|
|||||
|
2025
Q1 | $51.9M | Sell |
|
|||||
|
2024
Q4 | $50.9M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $15.1M | Sell |
|
|||||
|
2019
Q4 | $28.7M | Sell |
|
|||||
|
2019
Q3 | $22.5M | Sell |
|
|||||
|
2019
Q2 | $31.6M | Buy |
|
|||||
|
2019
Q1 | $29.9M | Buy |
|
|||||
|
2018
Q4 | $19.7M | Buy |
|
|||||
|
2018
Q3 | $15M | Sell |
|
|||||
|
2018
Q2 | $22.5M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $18.4M | Sell |
|
|||||
|
2016
Q2 | $15.4M | Buy |
|